These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 17467553)

  • 1. Macrolides in cystic fibrosis.
    McArdle JR; Talwalkar JS
    Clin Chest Med; 2007 Jun; 28(2):347-60. PubMed ID: 17467553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolides and airway inflammation in children.
    Shinkai M; Rubin BK
    Paediatr Respir Rev; 2005 Sep; 6(3):227-35. PubMed ID: 16153572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.
    López-Boado YS; Rubin BK
    Curr Opin Pharmacol; 2008 Jun; 8(3):286-91. PubMed ID: 18339582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA; Wolfs TF; Fleer A; Kimpen JL; van der Ent CK
    Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
    Phaff SJ; Tiddens HA; Verbrugh HA; Ott A
    J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of long term antibiotics in chronic respiratory diseases.
    Suresh Babu K; Kastelik J; Morjaria JB
    Respir Med; 2013 Jun; 107(6):800-15. PubMed ID: 23522403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapidly progressive lung disease in a patient with cystic fibrosis on long-term azithromycin: possible role of mycoplasma infection.
    Janahi IA; Abdulwahab A; Elshafie Sittana S; Bush A
    J Cyst Fibros; 2005 Mar; 4(1):71-3. PubMed ID: 15752685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term macrolide treatment for chronic respiratory disease.
    Spagnolo P; Fabbri LM; Bush A
    Eur Respir J; 2013 Jul; 42(1):239-51. PubMed ID: 23180583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory therapy in cystic fibrosis.
    Dinwiddie R
    J Cyst Fibros; 2005 Aug; 4 Suppl 2():45-8. PubMed ID: 16005266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Why use long-term macrolide therapy in pediatric pulmonology?].
    Corvol H; Taytard J; Thouvenin G; Périsson C; Nathan N; Clement A
    Arch Pediatr; 2014 Mar; 21(3):314-21. PubMed ID: 24503457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
    Bush A
    Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis.
    Sibley CD; Parkins MD; Rabin HR; Surette MG
    Curr Opin Investig Drugs; 2009 Aug; 10(8):787-94. PubMed ID: 19649923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of macrolides and tetracyclines for chronic inflammatory diseases.
    Voils SA; Evans ME; Lane MT; Schosser RH; Rapp RP
    Ann Pharmacother; 2005 Jan; 39(1):86-94. PubMed ID: 15562139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide antibiotics and bronchiolitis obliterans following lung transplantation.
    Crowley S; Egan JJ
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):923-30. PubMed ID: 16307505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin for improving pulmonary function in cystic fibrosis.
    Carr RR; Nahata MC
    Ann Pharmacother; 2004 Sep; 38(9):1520-4. PubMed ID: 15213312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolide antibiotics, bacterial populations and inflammatory airway disease.
    Swords WE; Rubin BK
    Neth J Med; 2003 Jul; 61(7):242-8. PubMed ID: 14567521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis pulmonary guidelines: airway clearance therapies.
    Flume PA; Robinson KA; O'Sullivan BP; Finder JD; Vender RL; Willey-Courand DB; White TB; Marshall BC;
    Respir Care; 2009 Apr; 54(4):522-37. PubMed ID: 19327189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory approaches to the treatment of cystic fibrosis lung disease: past, present and future.
    Oermann CM
    Curr Opin Investig Drugs; 2001 Jul; 2(7):900-6. PubMed ID: 11757788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.